Imatinib was teratogenic in rats when administered during organogenesis at doses ≥ 100 mg/ kg, approximately equal to the maximum clinical dose of 800 mg/ day, based on body surface area.
Rotilla imatinibi oli teratogeeninen, kun sitä annettiin organogeneesin aikana ≥ 100 mg/ kg annoksilla, vastaten noin 800 mg/ vrk maksimiannosta ihmiselle perustuen kehon pinta- alaan.